Answer
Zoledronic acid's selective action on bone reflects its high affinity for mineralised bone as a bisphosphonate, although the precise molecular mechanism inhibiting osteoclastic activity remains unclear.
Sources for this answer
- Zoledronic acid 4 mg/5 ml concentrate for solution for infusionTillomed Laboratories Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked